With the recent advents of gene-editing technologies, how can we establish ethical guidelines to prevent the exploitations of these technologies in applications that are outside of conventional medicine?”

Health Science Inquiry encourages authors to publish the work under a Creative Commons Attribution 4.0 International licence (CC BY 4.0) that allows others to distribute, remix, tweak, and build upon the work, even commercially, as long as they credit the Author(s) for the original creation. Authors may however choose to have their work distributed under any of the Creative Commons licenses currently available by specifying their preferred licence in the publication agreement. A description of the Creative Commons licences is available here: https://creativecommons.org/licenses/